Asian subgroup analysis of the phase III LEAP-017 trial of lenvatinib plus pembrolizumab vs standard-of-care in previously treated metastatic colorectal cancer (mCRC)
Asian subgroup analysis of the phase III LEAP-017 trial of lenvatinib plus pembrolizumab vs standard-of-care in previously treated metastatic colorectal cancer (mCRC)
저자
Xu, R-H.; Chen, Z.; Teng, H-W.; Pan, H.; Zhong, H.; Takashima, A.; Yang, T-S.; Yeh, Y-M.; Deng, Y.; Kim, T. W.; Kim, T-Y.; Park, J. O.; Lee, M. A.; Lee, S.; Yeh, K-H.; Yoshino, T.; Fu, R.; Jain, R.; Adelberg, D. E.; Kawazoe, A.